Clinical trial
Study of Deferoxamine Mesylate in Intracerebral Hemorrhage
NCT02175225 is registered in ClinicalTrials.gov with Beth Israel Deaconess Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Study of Deferoxamine Mesylate in Intracerebral Hemorrhage
- Lead sponsor
- Beth Israel Deaconess Medical Center
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- October 31, 2014
- Completion date
- May 30, 2018
- Enrollment
- 294 (actual)
- Sites
- 28
Conditions
As the registry lists them; a condition with its own page is linked.
intracerebral hemorrhage